Te Ahumairangi Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.58M | Buy |
59,376
+9,624
| +19% | +$1.07M | 1.18% | 26 |
|
2025
Q1 | $5.58M | Sell |
49,752
-6,869
| -12% | -$770K | 1.18% | 27 |
|
2024
Q4 | $5.23M | Sell |
56,621
-24,145
| -30% | -$2.23M | 1.09% | 29 |
|
2024
Q3 | $6.73M | Sell |
80,766
-9,587
| -11% | -$799K | 1.19% | 29 |
|
2024
Q2 | $6.2M | Sell |
90,353
-1,610
| -2% | -$110K | 1.19% | 30 |
|
2024
Q1 | $6.74M | Buy |
91,963
+3,290
| +4% | +$241K | 1.17% | 32 |
|
2023
Q4 | $7.18M | Sell |
88,673
-28,200
| -24% | -$2.28M | 1.36% | 24 |
|
2023
Q3 | $8.76M | Sell |
116,873
-12,200
| -9% | -$914K | 1.42% | 22 |
|
2023
Q2 | $9.95M | Buy |
129,073
+16,185
| +14% | +$1.25M | 1.36% | 22 |
|
2023
Q1 | $9.37M | Buy |
112,888
+8,541
| +8% | +$709K | 1.34% | 22 |
|
2022
Q4 | $8.96M | Sell |
104,347
-21,865
| -17% | -$1.88M | 1.4% | 23 |
|
2022
Q3 | $7.79M | Sell |
126,212
-24,145
| -16% | -$1.49M | 1.32% | 26 |
|
2022
Q2 | $9.29M | Sell |
150,357
-270
| -0.2% | -$16.7K | 1.4% | 23 |
|
2022
Q1 | $8.96M | Buy |
150,627
+14,620
| +11% | +$869K | 1.22% | 31 |
|
2021
Q4 | $9.88M | Buy |
136,007
+10,000
| +8% | +$726K | 1.28% | 27 |
|
2021
Q3 | $8.8M | Sell |
126,007
-4,000
| -3% | -$279K | 1.21% | 29 |
|
2021
Q2 | $8.95M | Sell |
130,007
-9,500
| -7% | -$654K | 1.17% | 31 |
|
2021
Q1 | $9.02M | Buy |
139,507
+29,000
| +26% | +$1.87M | 1.16% | 32 |
|
2020
Q4 | $6.44M | Buy |
110,507
+22,300
| +25% | +$1.3M | 0.9% | 44 |
|
2020
Q3 | $5.57M | Buy |
+88,207
| New | +$5.57M | 0.95% | 39 |
|